Jufeng Xia

1.1k total citations
26 papers, 737 citations indexed

About

Jufeng Xia is a scholar working on Molecular Biology, Epidemiology and Hepatology. According to data from OpenAlex, Jufeng Xia has authored 26 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in Jufeng Xia's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Viral Infections and Immunology Research (3 papers) and RNA modifications and cancer (3 papers). Jufeng Xia is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Viral Infections and Immunology Research (3 papers) and RNA modifications and cancer (3 papers). Jufeng Xia collaborates with scholars based in Japan, China and United States. Jufeng Xia's co-authors include Wei Tang, Jianjun Gao, Yoshinori Inagaki, Norihiro Kokudo, Peipei Song, Kiyoshi Hasegawa, Hui Yu, Xiufeng Yan, Norihiro Kokudo and Zhipeng Sun and has published in prestigious journals such as PLoS ONE, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Jufeng Xia

26 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jufeng Xia Japan 17 273 110 86 80 77 26 737
Wen Xiong China 16 306 1.1× 64 0.6× 44 0.5× 90 1.1× 172 2.2× 48 860
Yan Cao China 21 539 2.0× 145 1.3× 46 0.5× 37 0.5× 183 2.4× 58 1.2k
Xiaotong Chen China 17 296 1.1× 100 0.9× 52 0.6× 73 0.9× 56 0.7× 78 824
Zheng Ma China 15 419 1.5× 126 1.1× 113 1.3× 28 0.3× 138 1.8× 32 990
Nana Yan China 17 282 1.0× 270 2.5× 104 1.2× 41 0.5× 238 3.1× 39 850
Lili Gu China 20 680 2.5× 155 1.4× 96 1.1× 38 0.5× 214 2.8× 47 1.2k
Linlin Wei China 14 207 0.8× 198 1.8× 37 0.4× 26 0.3× 73 0.9× 49 693
Hongchao Zhou China 15 294 1.1× 185 1.7× 88 1.0× 21 0.3× 69 0.9× 34 933
Qingduan Wang China 15 276 1.0× 106 1.0× 74 0.9× 44 0.6× 58 0.8× 36 631

Countries citing papers authored by Jufeng Xia

Since Specialization
Citations

This map shows the geographic impact of Jufeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jufeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jufeng Xia more than expected).

Fields of papers citing papers by Jufeng Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jufeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jufeng Xia. The network helps show where Jufeng Xia may publish in the future.

Co-authorship network of co-authors of Jufeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jufeng Xia. A scholar is included among the top collaborators of Jufeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jufeng Xia. Jufeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Jufeng. (2022). Liquid-liquid phase separation: A new perspective to understanding aging and pathogenesis. BioScience Trends. 16(5). 359–362. 8 indexed citations
2.
Xia, Jufeng, et al.. (2020). CAR-expressing NK cells for cancer therapy: a new hope. BioScience Trends. 14(5). 354–359. 22 indexed citations
3.
Xia, Jufeng, et al.. (2019). Stem cell secretome as a new booster for regenerative medicine. BioScience Trends. 13(4). 299–307. 63 indexed citations
4.
Xia, Jufeng, Ling Rong, Yoshinori Inagaki, et al.. (2018). Shufeng Jiedu Capsule and its active ingredients induce apoptosis, inhibit migration and invasion, and enhances doxorubicin therapeutic efficacy in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 99. 921–930. 28 indexed citations
5.
Xia, Jufeng, et al.. (2017). Linking biological and physical aging: Dynamical scaling of multicellular regeneration. Physical review. E. 96(6). 62418–62418. 8 indexed citations
6.
Xia, Jufeng, Yoshinori Inagaki, Jianjun Gao, et al.. (2017). Combination of Cinobufacini and Doxorubicin Increases Apoptosis of Hepatocellular Carcinoma Cells through the Fas- and Mitochondria-Mediated Pathways. The American Journal of Chinese Medicine. 45(7). 1537–1556. 31 indexed citations
7.
Xia, Jufeng, et al.. (2016). Advances of diagnostic and mechanistic studies of γ-glutamyl transpeptidase in hepatocellular carcinoma. Drug Discoveries & Therapeutics. 10(4). 181–187. 29 indexed citations
8.
Xia, Jufeng, Yoshinori Inagaki, Jianfeng Zhang, Ling Wang, & Peipei Song. (2016). Chinese medicine as complementary therapy for female infertility. Chinese Journal of Integrative Medicine. 23(4). 245–252. 34 indexed citations
9.
Xia, Jufeng, Jianjun Gao, & Wei Tang. (2016). Nosocomial infection and its molecular mechanisms of antibiotic resistance. BioScience Trends. 10(1). 14–21. 81 indexed citations
10.
Song, Peipei, et al.. (2016). Traditional, complementary, and alternative medicine: Focusing on research into traditional Tibetan medicine in China. BioScience Trends. 10(3). 163–170. 12 indexed citations
11.
Xia, Jufeng, et al.. (2015). Anti-tumor effects and cellular mechanisms of resveratrol. Drug Discoveries & Therapeutics. 9(1). 1–12. 88 indexed citations
12.
Sun, Zhipeng, et al.. (2015). Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials. BioScience Trends. 10(2). 85–91. 31 indexed citations
13.
Wang, Zhigang, et al.. (2014). Can gamma-glutamyl transferase levels contribute to a better prognosis for patients with hepatocellular carcinoma?. Drug Discoveries & Therapeutics. 8(3). 134–138. 16 indexed citations
14.
15.
Xia, Jufeng, Jialu Chen, Zhongmin Zhang, et al.. (2014). A map describing the association between effective components of traditional Chinese medicine and signaling pathways in cancer cells in vitro and in vivo. Drug Discoveries & Therapeutics. 8(4). 139–153. 32 indexed citations
16.
Xia, Jufeng, et al.. (2013). Methicillin-resistant Staphylococcus aureus antibiotic resistance and virulence. BioScience Trends. 7(3). 113–21. 38 indexed citations
17.
Xia, Jufeng. (2013). Flavonoids as potential anti-hepatocellular carcinoma agents: Recent approaches using HepG2 cell line. Drug Discoveries & Therapeutics. 7(1). 1–8. 39 indexed citations
18.
Jia, Peilin, Fei Li, Jufeng Xia, et al.. (2012). Consensus Rules in Variant Detection from Next-Generation Sequencing Data. PLoS ONE. 7(6). e38470–e38470. 23 indexed citations
19.
Xia, Jufeng, et al.. (2011). Simple and rapid detection of human enterovirus 71 by reverse-transcription and loop-mediated isothermal amplification: cryopreservation affected the detection ability. Diagnostic Microbiology and Infectious Disease. 71(3). 244–251. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Xiong Breakdown of academic impact, for papers by Yan Cao Breakdown of academic impact, for papers by Xiaotong Chen Breakdown of academic impact, for papers by Zheng Ma Breakdown of academic impact, for papers by Nana Yan Breakdown of academic impact, for papers by Lili Gu Breakdown of academic impact, for papers by Linlin Wei Breakdown of academic impact, for papers by Hongchao Zhou Breakdown of academic impact, for papers by Qingduan Wang
Rankless by CCL
2026